Jacob Naarden Van

Affiliations

  • Evp & Pres., Lilly Oncology at Eli Lilly & Co (LLY), 2025-02-12
  • Chief Operating Officer at Loxo Oncology Inc. (LOXO), 2019-02-15
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
LOXO $140.16 541 $75,826.56 13,700 2018-12-11 Filing
LOXO $139.23 500 $69,615.00 14,241 2018-12-11 Filing
LOXO $137.73 500 $68,865.00 14,741 2018-12-11 Filing
LOXO $137.09 1,759 $241,141.31 15,241 2018-12-11 Filing
LOXO $135.92 800 $108,736.00 17,000 2018-12-11 Filing